Ephrin type-A receptor 3 (EPHA3) is a receptor tyrosine kinase involved in many biological functions, including migration, adhesion, and so on. Dysregulation of the EPHA3 receptor gene can lead to various oncogenic events, such as prostate cancer and hepatocellular carcinoma. Therefore, in silico SNP analysis is required to screen out the deleterious SNPs. Using ten bioinformatics tools, 41 non-synonymous SNPs (nsSNPs) were predicted as potentially harmful among 631 nsSNPs retrieved from the dbSNP database and as non-synonymous SNPs alter the wild-type amino acids; these substitutions may lead to deformity of the structure and hamper proper functionality of the protein. ConSurf review showed that all 41 harmful SNPs were mainly found in hea...
P bodies are 100-300 nm sized organelles involved in mRNA silencing and degradation. A total of 60 h...
The Eph receptor tyrosine kinase/ephrin ligand system regulates a wide spectrum of physiological pro...
Summary: Eph receptors and their ephrin ligands are viewed as promising targets for cancer treatment...
ErbB3 is a significant oncogenic target that is involved in the development of numerous malignancies...
Review on EPHA3 (EPH receptor A3), with data on DNA, on the protein encoded, and where the gene is i...
The Androgen Receptor (AR), an important ligand-dependent nuclear transcription factor, encoded by t...
Single nucleotide polymorphisms (SNPs) help to understand the phenotypic variations in humans. Genom...
The Eph receptor tyrosine kinase/ephrin ligand system regulates a wide spectrum of physi-ological pr...
The Harvey rat sarcoma (HRAS) proto-oncogene belongs to the RAS family and is one of the pathogenic ...
The implication of the transmembrane signalling Receptor Tyrosine Kinases (RTKs) in cancer has accel...
Eph receptors are the largest family of receptor tyrosine kinases. Together with their ligands, the ...
Eph receptors are the largest family of receptor tyrosine kinases. Together with their ligands, the ...
The focus of this work is EphA2, a member of the Eph family of receptor tyrosine kinases that has be...
Eph receptors are the largest family of receptor tyrosine kinases. Together with their ligands, the ...
Ephrin A2 receptor (EphA2) plays a key role in cancer, it is up-regulated in several types of tumors...
P bodies are 100-300 nm sized organelles involved in mRNA silencing and degradation. A total of 60 h...
The Eph receptor tyrosine kinase/ephrin ligand system regulates a wide spectrum of physiological pro...
Summary: Eph receptors and their ephrin ligands are viewed as promising targets for cancer treatment...
ErbB3 is a significant oncogenic target that is involved in the development of numerous malignancies...
Review on EPHA3 (EPH receptor A3), with data on DNA, on the protein encoded, and where the gene is i...
The Androgen Receptor (AR), an important ligand-dependent nuclear transcription factor, encoded by t...
Single nucleotide polymorphisms (SNPs) help to understand the phenotypic variations in humans. Genom...
The Eph receptor tyrosine kinase/ephrin ligand system regulates a wide spectrum of physi-ological pr...
The Harvey rat sarcoma (HRAS) proto-oncogene belongs to the RAS family and is one of the pathogenic ...
The implication of the transmembrane signalling Receptor Tyrosine Kinases (RTKs) in cancer has accel...
Eph receptors are the largest family of receptor tyrosine kinases. Together with their ligands, the ...
Eph receptors are the largest family of receptor tyrosine kinases. Together with their ligands, the ...
The focus of this work is EphA2, a member of the Eph family of receptor tyrosine kinases that has be...
Eph receptors are the largest family of receptor tyrosine kinases. Together with their ligands, the ...
Ephrin A2 receptor (EphA2) plays a key role in cancer, it is up-regulated in several types of tumors...
P bodies are 100-300 nm sized organelles involved in mRNA silencing and degradation. A total of 60 h...
The Eph receptor tyrosine kinase/ephrin ligand system regulates a wide spectrum of physiological pro...
Summary: Eph receptors and their ephrin ligands are viewed as promising targets for cancer treatment...